Press release
ANCA Vasculitis Pipeline Drugs, FDA Approvals, and Companies 2024
ANCA Vasculitis Pipeline
Explore our latest breakthroughs in ANCA Vasculitis Research. Learn more about our innovative pipeline today! @ ANCA Vasculitis Pipeline Outlook- https://www.delveinsight.com/sample-request/anca-vasculitis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Key Takeaways from the ANCA Vasculitis Pipeline Report
• June 2024:- Amgen- A Randomized, Double-blind, Placebo-controlled Phase 4 Clinical Trial to Evaluate the Long-term Safety and Efficacy of Avacopan in Subjects With Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis. The primary objective of this study is to evaluate the long-term safety of avacopan in participants with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV).
• June 2024:- Alpine Immune Sciences Inc.- An Open-Label, Multiple-Ascending Dose Study to Assess the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of Different Dose Levels of Povetacicept in Subjects With Autoantibody-Associated Glomerular Diseases (RUBY-3). The goal of this clinical study is to evaluate multiple dose levels of povetacicept (ALPN-303) in adults with immunoglobulin A (IgA) nephropathy, membranous nephropathy, lupus-related kidney disease (lupus nephritis). or anti-neutrophil cytoplasmic antibody (ANCA) associated vasculitis to determine if povetacicept is safe and potentially beneficial in treating these diseases.
• DelveInsight's ANCA Vasculitis pipeline report depicts a robust space with 12+ active players working to develop 12+ pipeline therapies for ANCA Vasculitis treatment.
• The leading ANCA Vasculitis Companies such as Bristol-Myers Squibb, Travere Therapeutics, Novartis Pharmaceuticals, NS Pharma, Staidson Biopharmaceuticals Co., Ltd., and others.
• Promising ANCA Vasculitis Therapies such as BDB-001 injection, Cyclophosphamide, Glucocorticoids, Avacopan, Iptacopan, NM8074, and others.
Stay informed about the cutting-edge advancements in ANCA Vasculitis Treatments. Download for updates and be a part of the revolution in Cardiovascular Diseases care @ ANCA Vasculitis Clinical Trials Assessment- https://www.delveinsight.com/sample-request/anca-vasculitis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
ANCA Vasculitis Emerging Drugs Profile
• Abatacept: Bristol-Myers Squibb
Abatacept is a selective T-cell co-stimulation modulator. Abatacept binds to CD80 and CD86 receptors on antigen-presenting cells (APCs), which are essential for T-cell activation. This binding blocks the interaction between CD80/CD86 and CD28, thereby inhibiting the delivery of the second co-stimulatory signal required for optimal T-cell activation. Currently, the drug is in Phase III stage of its clinical trial for the treatment of ANCA Vasculitis.
• Sparsentan : Travere Therapeutics
Sparsentan is a dual endothelin and angiotensin II receptor antagonist used to reduce proteinuria in adults with primary immunoglobulin A nephropathy (IgAN) at risk of rapid disease progression. Sparsentan acts as a dual antagonist of the endothelin type A receptor (ETAR) and the angiotensin II type 1 receptor (AT1R), which are involved in the pathogenesis of IgAN. It selectively blocks the action of endothelin-1 (ET-1) and angiotensin II (Ang II) at their respective receptors, thereby reducing proteinuria. The drug is currently in Phase II of clinical trial evaluation for the treatment of ANCA Associated Vasculitis.
Learn more about ANCA Vasculitis Drugs opportunities in our groundbreaking ANCA Vasculitis Research and development projects @ ANCA Vasculitis Unmet Needs- https://www.delveinsight.com/sample-request/anca-vasculitis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
ANCA Vasculitis pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration
• Oral
• Intravenous
• Subcutaneous
• Parenteral
• Topical
ANCA Vasculitis Products have been categorized under various Molecule types such as
• Recombinant fusion proteins
• Small molecule
• Monoclonal antibody
• Peptide
• Polymer
• Gene therapy
Discover the latest advancements in ANCA Vasculitis Treatment by visiting our website. Stay informed about how we're transforming the future of cardiovascular disease @ ANCA Vasculitis Market Drivers and Barriers, and Future Perspectives- https://www.delveinsight.com/sample-request/anca-vasculitis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Scope of the ANCA Vasculitis Pipeline Report
• Coverage- Global
• ANCA Vasculitis Companies- Bristol-Myers Squibb, Travere Therapeutics, Novartis Pharmaceuticals, NS Pharma, Staidson Biopharmaceuticals Co., Ltd., and others.
• ANCA Vasculitis Therapies- BDB-001 injection, Cyclophosphamide, Glucocorticoids, Avacopan, Iptacopan, NM8074, and others.
• ALK-positive Non-Small Cell Lung Cancer Therapeutic Assessment by Product Type: Mono, Combination, Mono/Combination
• ALK-positive Non-Small Cell Lung Cancer Therapeutic Assessment by Clinical Stages: Discovery, Pre-clinical, Phase I, Phase II, Phase III
For a detailed overview of our latest research findings and future plans, read the full details of ANCA Vasculitis Pipeline on our website @ ANCA Vasculitis Drugs and Companies- https://www.delveinsight.com/sample-request/anca-vasculitis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Table of Content
1. Introduction
2. Executive Summary
3. ANCA Vasculitis: Overview
4. Pipeline Therapeutics
5. Therapeutic Assessment
6. ANCA Vasculitis - DelveInsight's Analytical Perspective
7. Late Stage Products (Phase III)
8. Abatacept: Bristol-Myers Squibb
9. Drug profiles in the detailed report…..
10. Mid Stage Products (Phase II)
11. Sparsentan: Travere Therapeutics
12. Drug profiles in the detailed report…..
13. Early Stage Products (Phase I/II)
14. Drug name: Company name
15. Drug profiles in the detailed report…..
16. Preclinical and Discovery Stage Products
17. Drug name: Company name
18. Drug profiles in the detailed report…..
19. Inactive Products
20. ANCA Vasculitis Key Companies
21. ANCA Vasculitis Key Products
22. ANCA Vasculitis- Unmet Needs
23. ANCA Vasculitis- Market Drivers and Barriers
24. ANCA Vasculitis- Future Perspectives and Conclusion
25. ANCA Vasculitis Analyst Views
26. ANCA Vasculitis Key Companies
27. Appendix
List of Top Selling Market Research Reports in 2024
Surgical Energy Generators Market- https://www.delveinsight.com/report-store/surgical-energy-generators-market
Surgical Sealant Tissue Patch Market- https://www.delveinsight.com/report-store/surgical-sealant-tissue-patch-market
Surgical Stapling Devices Market- https://www.delveinsight.com/report-store/surgical-stapling-devices-market
Vital Sign Monitoring Devices Market- https://www.delveinsight.com/report-store/vital-sign-monitors-external-remote-patient-monitoring-devices-market
Syphilis Market- https://www.delveinsight.com/report-store/syphilis-market
Vitreoretinal Surgery Devices Market- https://www.delveinsight.com/report-store/vitreoretinal-surgery-devices-market
Pelvic Organ Prolapse Market- https://www.delveinsight.com/report-store/pelvic-organ-prolapse-market
Scoliosis Market- https://www.delveinsight.com/report-store/scoliosis-market
SGLT2 Inhibitors Market- https://www.delveinsight.com/report-store/sglt2-inhibitors-market
Urinary Catheters Market- https://www.delveinsight.com/report-store/urinary-catheters-market
Carcinoid Syndrome Market- https://www.delveinsight.com/report-store/carcinoid-syndrome-market
Cardiac Monitoring Devices Market- https://www.delveinsight.com/report-store/cardiac-monitoring-devices-market
Varicose Vein Treatment Devices Market- https://www.delveinsight.com/report-store/varicose-vein-treatment-devices-market
Bone Growth Stimulators Market- https://www.delveinsight.com/report-store/bone-growth-stimulators-market
Skin Neoplasms Market- https://www.delveinsight.com/report-store/skin-neoplasms-market
Thrombectomy Devices Market- https://www.delveinsight.com/report-store/thrombectomy-devices-market
Novel Drug Delivery Devices Market- https://www.delveinsight.com/report-store/novel-drug-delivery-devices
Lymphedema Market- https://www.delveinsight.com/report-store/lymphedema-market
Artificial Disc Market- https://www.delveinsight.com/report-store/artificial-disc-market
Exocrine Pancreatic Insufficiency Market- https://www.delveinsight.com/report-store/exocrine-pancreatic-insufficiency-epi-market
Fabry Disease Market- https://www.delveinsight.com/report-store/fabry-disease-market
Overactive Bladder Market- https://www.delveinsight.com/report-store/overactive-bladder-oab-market
Total Knee Arthroplasty Market- https://www.delveinsight.com/report-store/total-knee-arthroplasty-market
Hip Replacement Devices Market- https://www.delveinsight.com/report-store/hip-reconstruction-devices-market
Lactose Intolerance Market- https://www.delveinsight.com/report-store/lactose-intolerance-market
HDAC Inhibitors Market- https://www.delveinsight.com/report-store/hdac-inhibitors-market
Ventral Hernia Market- https://www.delveinsight.com/report-store/ventral-hernia-market
Facial Lines Market- https://www.delveinsight.com/report-store/facial-lines-market
Medical Marijuana Market- https://www.delveinsight.com/report-store/medical-marijuana-market-insight
Microscopy Device Market- https://www.delveinsight.com/report-store/microscopy-device-market
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Yash Bhardwaj
info@delveinsight.com
+91-9650213330
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release ANCA Vasculitis Pipeline Drugs, FDA Approvals, and Companies 2024 here
News-ID: 3634998 • Views: …
More Releases from DelveInsight Business Research LLP
Brain Cancer Market Size is Set for Rapid Growth as Innovative Treatments and Ri …
The market size of Brain Cancer is expected to increase during the forecast period with the increasing prevalence, disease awareness, and promising emerging treatment options by leading companies such as Genentech, Merck, Azurity Pharmaceuticals, Sevier, Kazia Therapeutics, Chimerix, Aivita Bio-medical, Medicenna Therapeutics
[Nevada, United States] - DelveInsight's "Brain Cancer Market Insights, Epidemiology, and Market Forecast 2034." report offers a detailed examination of Brain Cancer, covering historical and predicted epidemiology, market trends,…
Non-Small Cell Lung Cancer (NSCLC) Market to Witness Upsurge in Growth During th …
The market size of Non-Small Cell Lung Cancer (NSCLC) is expected to increase during the forecast period with the increasing prevalence, disease awareness, and promising emerging treatment options by leading companies such as novartis Pharmaceuticals, Novartis Pharmaceuticals, AbbVie, Janssen Pharmaceuticals, Xcovery, Eli Lilly and Company Sanofi, Pfizer, Astellas Pharma/Seattle Genetics, Takeda Pharmaceuticals, Novartis, Merck/Pfizer, Mirati Therapeutics/Bristol-Myers Squibb/Beigene, Merck/GlaxoSmithKline, Amgen, Incyte Corporation.
[Nevada, United States] - DelveInsight's "Non-Small Cell Lung Cancer (NSCLC)…
Ascites Market Size is Set for Rapid Growth as Innovative Treatments and Rising …
The market size of Ascites is expected to increase during the forecast period with the increasing prevalence, disease awareness, and promising emerging treatment options by leading companies such as Ocelot Bio, PharmaIN, Genfit, NovaShunt AG, Wuhan YZY Biopharma Co., Ltd., Neovii Biotech, Protgen Ltd, Movetis, Sanofi, BioVie Inc., Versantis AG, Ocelot Bio, Inc, Mallinckrodt.
[Nevada, United States] - DelveInsight's "Ascites Market Insights, Epidemiology, and Market Forecast 2034." report offers a detailed…
Aplastic Anemia Market Size is Set for Rapid Growth as Innovative Treatments and …
The market size of Aplastic Anemia is expected to increase during the forecast period with the increasing prevalence, disease awareness, and promising emerging treatment options by leading companies such as Pfizer, BioLineRx Ltd., Regeneron Pharmaceuticals, Gamida Cell, Elixirgen, Hangzhou Zede Pharmaceutical Technology, Cellenkos, Hemogenyx Pharmaceuticals.
[Nevada, United States] - DelveInsight's "Aplastic Anemia Market Insights, Epidemiology, and Market Forecast 2034." report offers a detailed examination of Aplastic Anemia, covering historical and predicted…
More Releases for ANCA
ANCA Vasculitis Drug Market Top Leading Players with Strategies and Forecast 202 …
The global ANCA vasculitis drug market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). ANCA vasculitis is an autoimmune disease that affects the body's tiny blood vessels. Autoantibodies known as ANCAs, or Anti-Neutrophilic Cytoplasmic Autoantibodies, cause it. Neutrophils are a type of white blood cell that ANCAs target and attack. They go after the cytoplasm, which is a portion of neutrophils (the inside of the…
Grinding Machines Market: Junker Group, Kellenberger & Co. AG, ANCA Pty Ltd.
MarketResearchReports.Biz has recently announced the Latest industry research report on: "Global Grinding Machines Market" : Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts.
This report presents the worldwide Grinding Machines market size (value, production and consumption), splits the breakdown (data status 2013-2018 and forecast to 2025), by manufacturers, region, type and application.
This study also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities…
ANCA Associated Diseases/Vasculitis Market Value Projected to Expand by 2025
Vasculitis is an autoimmune disease in which the body comes under attack from its own immune system, especially neutrophils, and in some cases it is also caused by reactions to medicines. It is a term for a group of rare diseases that are characterized by a condition that destroys blood vessels through inflammation. It can range from mild to life threatening and short term to long term. Vasculitis is caused…
Olialia Chairperson ANCA VERMA conferred with BR Ambedkar Award ~ April 19, 2018
Olialia Chairperson Mrs. Anca Verma former Romanian Supermodel was conferred with Baba Sahib Dr.Bhim Rao Ambedkar Award on the 19th April 2018, by the Union Minister for Social Justice Mr. Thavar Chand Gehlot in New Delhi.
Besides the Chief Guest, other Guests of Honour, such as Congress Leader Mrs. Usha Krishna Kumar, and other IAS and IPS officers and their wives were present to grace the occasion.
The award was in recognition…
ANCA Associated Diseases/Vasculitis Market Shares, Strategies and Forecast World …
Vasculitis is an autoimmune disease in which the body comes under attack from its own immune system, especially neutrophils, and in some cases it is also caused by reactions to medicines. It is a term for a group of rare diseases that are characterized by a condition that destroys blood vessels through inflammation. It can range from mild to life threatening and short term to long term. Vasculitis is caused…
Anca Verma honored with the prestigious ‘Woman Entrepreneur of the Year 2018†…
New Delhi ~ 30th March 2018
Anca Verma, the wife of billionaire industrialist Abhishek Verma, recently was awarded the illustrious ‘Women Entrepreneur of the Year 2018’ Award at an event held in New Delhi.
The 7th Asiad Literature Festival was organized to celebrate women’s achievements on the International Women’s Day, and promoting ‘I AM KHADI from Local to Global’ as well as ‘UdaanSkill’, a measure aimed at women empowerment.
Organized on March…
